Harnessing oncolytic virus-mediated immunity
Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-onco...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Online |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Frontiers Media SA
2021
|
| Fáttát: | |
| Liŋkkat: | 18596 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid: Harnessing oncolytic virus-mediated immunity
- Molecular Therapy: Oncolytics
- Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy
- Oncolytic Virus Immunotherapy
- Immunogenic Cell Death in Cancer: From Benchside Research to Bedside
- Tumor Cell/Dendritic Cell Interactions and the Influence of Tumors on Dendritic Cell-mediated Anti-Tumor Immune Responses and Dendritic Cell-Based Tumor Immunotherapies
- Molecular Cancer